Company profile
CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC.
NASDAQ:CELZBiotechnology: Biological Products (No Diagnostic Substances)
Clinical trials (2)
| NCT ID | Phase | Status | Start | Completion | Sponsor name | Title |
|---|---|---|---|---|---|---|
| NCT05626712 | phase1_2 | recruiting | 2023-04-07 | 2027-01-31 | Creative Medical Technology Holdings Inc | Safety and Efficacy of CELZ-201 in Patients With Recent Onset Type 1 Diabetes |
| NCT06053242 | phase1_2 | active_not_recruiting | 2024-05-21 | 2027-01-20 | Creative Medical Technology Holdings Inc | Safety, Tolerability, and Effectiveness of Intramuscular Injection of CELZ-201-DDT for the Treatment of Chronic Lower Back Pain |
FDA applications (0)
No records yet.